FierceBiotech 20. Mai 2026 With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate
FierceBiotech 20. Mai 2026 Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues
Amgen 20. Mai 2026 Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns - Contract Pharma
Pfizer 20. Mai 2026 Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175M - Endpoints News
Qiagen 20. Mai 2026 Qiagen links with chip giant Nvidia to propel AI use in drug discovery - Fierce Biotech
Eli Lilly 20. Mai 2026 Lilly pens $202M deal for preclinical DNA delivery biotech Engage as M&A streak continues - Fierce Biotech
BioPharma Dive 20. Mai 2026 Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update
FierceBiotech 20. Mai 2026 BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Lonza News 20. Mai 2026 Oxford Nanopore and Lonza Launch mRNA QC Solution for GMP Testing - Contract Pharma
Endpoints News 20. Mai 2026 Fetal gene therapy's progress calls into question the taboo on embryo editing
Amgen 20. Mai 2026 Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus - Fierce Pharma